Plus   Neg

Stock Alert: Nurix Therapeutics Gains 8%

Shares of Nurix Therapeutics Inc. (NRIX) are gaining over 8% on Friday morning. The biopharmaceutical company announced pricing of upsized public offering, raising $139.5 million.

NRIX is currently trading at $35.35, up $2.86 or 8.80%, on the Nasdaq.

Nurix Therapeutics priced its offering of 4.5 million common shares at $31.00 per share. The offering was upsized from the previously announced size of 4 million shares.

The proceeds are expected to be $139.5 million. The offering is expected to close on March 9, 2021.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Fast-food giant McDonald's said it will be raising hourly wages for more than 36,500 hardworking employees at McDonald's-owned restaurants by an average of 10 percent to make it among the industry-leading pay and benefits package. These increases, which have already begun, will be rolled out over the next several months. Biogen Inc. (BIIB) Friday said its XIRIUS study of cotoretigene toliparvovec failed to meet its primary endpoint in Phase 2/3 in patients with X-linked retinitis pigmentosa or XLRP. The company further noted that the study obtained positive trends in other pre-specified clinically relevant endpoints,... General Mills Inc. (GIS) agreed to buy Tyson Foods' (TSN) pet treats business for $1.2 billion in cash, the companies said in a statement on Friday. The transaction includes the Nudges, Top Chews and True Chews brands. General Mills will also acquire a manufacturing facility in Independence, Iowa.
Follow RTT